From Trials to Clinics: Considerations for Implementing Psychedelic‐Assisted Therapy Into Clinical Practice
Pharmacology Research & Perspectives · 2026-06 · 14 (3)
DOI: 10.1002/prp2.70262 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacology Research & Perspectives, online erschienen am 10.05.2026. Verfasst von Jessie Kim und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, University of California San Diego, San Diego, California, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Psychiatry, University of California San Diego, San Diego, California, USA.
- University of Queensland School of Medicine, Herston, Queensland, Australia.
Zitieren
APA
Kim, J., Lochhead, L., & Weissman, C. R. (2026). From Trials to Clinics: Considerations for Implementing Psychedelic‐Assisted Therapy Into Clinical Practice. Pharmacology Research & Perspectives, 14(3). https://doi.org/10.1002/prp2.70262
Vancouver
Kim J, Lochhead L, Weissman CR. From Trials to Clinics: Considerations for Implementing Psychedelic‐Assisted Therapy Into Clinical Practice. Pharmacology Research & Perspectives. 2026;14(3). doi:10.1002/prp2.70262
BibTeX
@article{Kim2026,
author = {Kim, Jessie and Lochhead, Liam and Weissman, Cory R},
title = {From Trials to Clinics: Considerations for Implementing Psychedelic‐Assisted Therapy Into Clinical Practice},
journal = {Pharmacology Research & Perspectives},
year = {2026},
volume = {14},
number = {3},
doi = {10.1002/prp2.70262}
}
EUVIMED